NCT05800600View on ClinicalTrials.gov

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2027

Conditions
Anemia
Interventions
DRUG

Venofer

Intravenous iron will be administered as five doses of 200 mg of iron sucrose (Venofer, American Regent, Shirley, NJ) in 100 ml normal saline over a duration of 15 minutes to 1 hour

Trial Locations (1)

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER